000 | 02625 a2200781 4500 | ||
---|---|---|---|
005 | 20250517122050.0 | ||
264 | 0 | _c20180212 | |
008 | 201802s 0 0 eng d | ||
022 | _a1949-2553 | ||
024 | 7 |
_a10.18632/oncotarget.12640 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Pei Y | |
245 | 0 | 0 |
_aThe BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs. _h[electronic resource] |
260 |
_bOncotarget _cNov 2016 |
||
300 |
_a79217-79232 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 |
_aAzepines _xadministration & dosage |
650 | 0 | 4 | _aCell Cycle Proteins |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xmetabolism |
650 | 0 | 4 |
_aNaphthoquinones _xadministration & dosage |
650 | 0 | 4 |
_aNeuroblastoma _xdrug therapy |
650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
650 | 0 | 4 |
_aProtein Domains _xdrug effects |
650 | 0 | 4 |
_aRNA-Binding Proteins _xmetabolism |
650 | 0 | 4 |
_aSmall Molecule Libraries _xadministration & dosage |
650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
650 | 0 | 4 |
_aTriazoles _xadministration & dosage |
650 | 0 | 4 |
_aTubulin Modulators _xadministration & dosage |
650 | 0 | 4 |
_aVincristine _xadministration & dosage |
650 | 0 | 4 | _aXenograft Model Antitumor Assays |
700 | 1 | _aSokolowski, Nicholas | |
700 | 1 | _aGuo, Su T | |
700 | 1 | _aSiddiqi, Faraz | |
700 | 1 | _aAtmadibrata, Bernard | |
700 | 1 | _aTelfer, Thomas J | |
700 | 1 | _aSun, Yuting | |
700 | 1 | _aZhang, Lihong | |
700 | 1 | _aYu, Denise | |
700 | 1 | _aMccarroll, Joshua | |
700 | 1 | _aLiu, Bing | |
700 | 1 | _aYang, Rui H | |
700 | 1 | _aGuo, Xiang Y | |
700 | 1 | _aTee, Andrew E | |
700 | 1 | _aItoh, Ken | |
700 | 1 | _aWang, Jenny | |
700 | 1 | _aKavallaris, Maria | |
700 | 1 | _aHaber, Michelle | |
700 | 1 | _aNorris, Murray D | |
700 | 1 | _aCheung, Belamy B | |
700 | 1 | _aByrne, Jennifer A | |
700 | 1 | _aZiegler, David S | |
700 | 1 | _aMarshall, Glenn M | |
700 | 1 | _aDinger, Marcel E | |
700 | 1 | _aCodd, Rachel | |
700 | 1 | _aZhang, Xu D | |
700 | 1 | _aLiu, Tao | |
773 | 0 |
_tOncotarget _gvol. 7 _gno. 48 _gp. 79217-79232 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.12640 _zAvailable from publisher's website |
999 |
_c26535699 _d26535699 |